HomeAbout

TL;DR CNBC


Biden administration asks Pfizer, Moderna and Novavax for 'reasonable' prices on updated Covid vaccines - TL;DR CNBC

Biden administration asks Pfizer, Moderna and Novavax for 'reasonable' prices on updated Covid vaccines

Publishing timestamp: 2023-07-13 18:57:17


Summary

The Biden administration has urged Pfizer, Moderna, and Novavax to price their updated Covid vaccines at a "reasonable" rate when they are released in the US this fall. The manufacturers have not disclosed the exact pricing of their vaccines yet. The government is expected to shift Covid vaccine distribution to the commercial market, so the price points for the vaccines will be crucial. Lawmakers have criticized the expected price increase for the vaccines, as the companies have already made significant profits during the pandemic. The manufacturers are expected to work with healthcare providers and payors to ensure coverage for the updated shots. Federal and corporate programs are also planning to help cover the costs for uninsured Americans. However, there are still questions about the details of these efforts.


Sentiment: NEUTRAL

Tickers: MRNANVAXPFE

Keywords: fdabiotech and pharmaceuticalscoronavirusvaccinationscenters for disease control and preventionbusinesspharmaceuticalsnovavax inchealth care industrybiotechnologymoderna incbreaking newsunited statesbusiness newsimmunizationsbreaking news: politicspoliticscovid-19pfizer inc

Source: https://www.cnbc.com/2023/07/13/updated-covid-vaccines-should-have-reasonable-prices-hhs.html


Developed by Leo Phan